The Relationship of Diabetes and Smoking Status to Hepatocellular Carcinoma Mortality
- PMID: 26871803
- PMCID: PMC4753898
- DOI: 10.1097/MD.0000000000002699
The Relationship of Diabetes and Smoking Status to Hepatocellular Carcinoma Mortality
Abstract
The relationship of diabetes and smoking status to hepatocellular carcinoma (HCC) mortality is not clear. We aimed to investigate the association of smoking cessation relative to diabetes status with subsequent deaths from HCC.We followed up 51,164 participants (aged 44-94 years) without chronic hepatitis B or C from 1 January 1998 to 31 December 2008 enrolled from nationwide health screening units in a prospective cohort study. The primary outcomes were deaths from HCC.During the study period, there were 253 deaths from HCC. History of diabetes was associated with deaths from HCC for both total participants (adjusted hazard ratio [HR], 2.97; 95% confidence interval [CI], 2.08-4.23) and ever smokers with current or past smoking habits (HR, 1.92; 95% CI, 1.10-3.34). Both never smokers (HR, 0.46; 95% CI, 0.32-0.65) and quitters (HR, 0.62; 95% CI, 0.39-0.97) had a lower adjusted risk of HCC deaths compared with current smokers. Among all ever smokers with current or past smoking habits, as compared with diabetic smokers, only quitters without diabetes had a lower adjusted risk of HCC deaths (HR, 0.37; 95% CI, 0.18-0.78). However, quitters with diabetes were observed to have a similar risk of deaths from HCC when compared with smokers with diabetes. Regarding the interaction between diabetes and smoking status on adjusted HCC-related deaths, with the exception of quitters without history of diabetes, all groups had significantly higher HRs than nondiabetic never smokers. There was also a significant multiplicative interaction between diabetes and smoking status on risk of dying from HCC (P = 0.033). We suggest clinicians should promote diabetes prevention and never smoking to associate with reduced subsequent HCC mortality even in adults without chronic viral hepatitis.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures


Similar articles
-
Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly.Hepatology. 2014 Jun;59(6):2207-15. doi: 10.1002/hep.27014. Epub 2014 Apr 3. Hepatology. 2014. PMID: 24425422
-
Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study.Lancet Diabetes Endocrinol. 2020 Feb;8(2):125-133. doi: 10.1016/S2213-8587(19)30413-9. Epub 2020 Jan 7. Lancet Diabetes Endocrinol. 2020. PMID: 31924561 Free PMC article.
-
Risk of death due to hepatocellular carcinoma among smokers and ex-smokers. Univariate analysis of JACC study data.Kurume Med J. 2004;51(1):71-81. doi: 10.2739/kurumemedj.51.71. Kurume Med J. 2004. PMID: 15150902
-
Influences of tobacco and alcohol use on hepatocellular carcinoma survival.Int J Cancer. 2012 Dec 1;131(11):2612-21. doi: 10.1002/ijc.27508. Epub 2012 Mar 28. Int J Cancer. 2012. PMID: 22362517
-
Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?Nicotine Tob Res. 2016 Dec;18(12):2216-2224. doi: 10.1093/ntr/ntw189. Epub 2016 Aug 18. Nicotine Tob Res. 2016. PMID: 27613928 Free PMC article.
Cited by
-
Prevalence and correlations of hepatorenal functions in diabetes and cardiovascular disease among stratified adults.Acta Biomed. 2019 Jan 22;90(1):97-103. doi: 10.23750/abm.v90i1.6576. Acta Biomed. 2019. PMID: 30889161 Free PMC article.
-
Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma.World J Gastroenterol. 2023 Jan 14;29(2):286-309. doi: 10.3748/wjg.v29.i2.286. World J Gastroenterol. 2023. PMID: 36687124 Free PMC article. Review.
-
Association of modifiable metabolic risk factors and lifestyle with all-cause mortality in patients with hepatocellular carcinoma.Sci Rep. 2024 Jul 4;14(1):15405. doi: 10.1038/s41598-024-65127-9. Sci Rep. 2024. PMID: 38965260 Free PMC article.
-
Tobacco, Cigarettes, and the Liver: The Smoking Gun.J Clin Exp Hepatol. 2021 Nov-Dec;11(6):700-712. doi: 10.1016/j.jceh.2021.07.016. Epub 2021 Aug 10. J Clin Exp Hepatol. 2021. PMID: 34866849 Free PMC article. Review.
-
Effects and Relative Factors of Adjunctive Chinese Medicine Therapy on Survival of Hepatocellular Carcinoma Patients: A Retrospective Cohort Study in Taiwan.Integr Cancer Ther. 2020 Jan-Dec;19:1534735420915275. doi: 10.1177/1534735420915275. Integr Cancer Ther. 2020. PMID: 32552053 Free PMC article.
References
-
- El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365:1118–1127. - PubMed
-
- Chen CL, Yang HI, Yang WS, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135:111–121. - PubMed
-
- Inoue M, Kurahashi N, Iwasaki M, et al. Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II). Cancer Causes Control 2009; 20:741–750. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous